Wecare Calasoothe recalled over manufacturing violations
- Recall date
- October 31, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Blossom Pharmaceuticals recalls Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 1096…
- Recall number
- D-0213-2026
- FDA classification
- Class II
- Brand / firm
- Blossom Pharmaceuticals
- Sold / distributed
- USA Nationwide
Why it was recalled
cGMP deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.
Get recall alerts
Free email alert whenever Blossom Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Blossom Pharmaceuticals